Medicine and Dentistry
Cancer in Young Adults
100%
Malignant Neoplasm
75%
Breast Cancer
72%
Quality of Life
72%
COVID-19
26%
Patient-Reported Outcome
26%
Metastatic Breast Cancer
26%
Neoplasm
22%
Health Outcomes
19%
Diseases
17%
Cancer Registry
17%
Body Image
14%
Receptor
14%
Clinician
13%
Cancer Prevention
13%
Cancer Research
13%
Cancer Prognosis
13%
Fertility Preservation
13%
Second Cancer
13%
Accelerated Aging
13%
Cancer Risk
13%
Social Interaction
13%
Clinical Trial
13%
Trastuzumab
13%
Cyclophosphamide
13%
Recurrence Free Survival
13%
Targeted Therapy
13%
Gene Expression
13%
Doxorubicin
13%
Premedication
13%
H1 Antagonist
13%
Histamine H1 Receptor
13%
Cetirizine
13%
Clemastine
13%
Paclitaxel
13%
Reproductive Medicine
13%
Intracranial Tumor
13%
Estrogen Receptor
13%
Tipiracil
13%
Arm
13%
Allergic Response
11%
Cryopreservation
11%
Intraductal Carcinoma
9%
Triple Negative Breast Cancer
9%
Hazard Ratio
9%
Logistic Regression Analysis
8%
Cancer Staging
8%
Randomized Controlled Trial
7%
Cohort Analysis
7%
Healthy Lifestyle
6%
Pharmacology, Toxicology and Pharmaceutical Science
Breast Cancer
45%
Malignant Neoplasm
36%
Metastatic Breast Cancer
26%
Trastuzumab
26%
Paclitaxel
26%
Chemotherapy
23%
Cyclophosphamide
16%
Doxorubicin
16%
Docetaxel
16%
Receptor
14%
Taxane
14%
Ribociclib
13%
Endoxifen
13%
Clinical Trial
13%
Tamoxifen
13%
Recurrence Free Survival
13%
Histamine H1 Receptor Antagonist
13%
Histamine H1 Receptor
13%
Clemastine
13%
Cetirizine
13%
Intracranial Tumor
13%
Trifluridine
13%
Tipiracil
13%
Estrogen Receptor
13%
Carboplatin
13%
Neuropathy
13%
Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer
13%
Allergic Reaction
11%
Neoplasm
9%
Overall Survival
9%
Anemia
9%
Anthracycline
6%
Febrile Neutropenia
6%
Triple Negative Breast Cancer
6%
Neutropenia
5%
Hormone Receptor
5%
Diseases
5%